https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2005-05-16 14:13:152016-11-28 14:13:41SuperGen Reports Results of Phase III Rescue Study With Orathecin™ (Rubitecan Capsules) Versus 5-FU in Pancreatic Cancer Patients
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2005-03-08 14:14:212016-11-28 14:14:44SuperGen Appoints Allan R. Goldberg, Ph.D. to Board of Directors
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2005-03-03 14:14:522016-11-28 14:15:13SuperGen Initiates Phase II Combination Trial of Orathecin™ and Gemcitabine in Chemotherapy Naive Pancreatic Cancer Patients
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2005-02-09 14:16:442016-11-28 14:17:05Dr. Joseph Rubinfeld Resigns From Supergen’s Board Of Directors
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2005-01-03 14:17:142016-11-28 14:17:39Dacogen™ NDA Accepted for Filing by FDA
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
